This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Gregg's Most Recent Article

No Reason to Avoid High-Yield Funds, Says Western Asset Strategist

07/31/15 - 11:57 AM EDT

The concerns about liquidity in the high-yield market are real but should stop you from investing, says Don Plotsky, head of Western Asset's product group.

read more >

Other Articles by Gregg

Free Reports

Don’t Fret High Yield Market Says Western Asset Strategist Don’t Fret High Yield Market Says Western Asset Strategist

07/31/15 - 11:44 AM EDT

The concerns about liquidity in the high yield market are real. Nevertheless, they should not keep investors from increasing their exposure to high yield funds.

read more >
Why You Should Sell Cummins, Avoid Ford and UPS Why You Should Sell Cummins, Avoid Ford and UPS

07/31/15 - 11:33 AM EDT

Cummins may have beaten Wall Street's expectations of its second quarter, but investors should still sell or even short the engine-maker's stock, says the editor of Rational Bear.

read more >
Ford, UPS Won’t Deliver for Shareholders Says Rational Bear Ford, UPS Won’t Deliver for Shareholders Says Rational Bear

07/31/15 - 10:48 AM EDT

Cummins (CMI) may have thoroughly beaten Wall Street’s consensus earnings forecast in its second quarter, but investors should still sell or even short the engine-maker’s stock.

read more >
Cynapsus CEO Says IPO Funds Will Help Parkinson’s Patients Get Unstuck Cynapsus CEO Says IPO Funds Will Help Parkinson’s Patients Get Unstuck

07/30/15 - 06:21 PM EDT

The Cynapsus IPO last month raised the company's visibility in the U.S., along with capital for pivotal trials of its Parkinson's drug-delivery system.

read more >
Parkinson’s Drug Delivery System on Track Says Cynapsus CEO Parkinson’s Drug Delivery System on Track Says Cynapsus CEO

07/30/15 - 04:01 PM EDT

Cynapsus move to list itself on the Nasdaq last month was more than an attempt to raise its visibility in the United States.

read more >
Four Stem-Cell Stocks With Promise Four Stem-Cell Stocks With Promise

07/30/15 - 02:19 PM EDT

Raymond James analyst Reni Benjamin says positive news may be ahead for these companies.

read more >
Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst

07/30/15 - 12:37 PM EDT

Fate Therapeutics (FATE) is developing several small molecules which modulate umbilical cord stem cells.

read more >
Why Pepsi, Time Warner Should Be in Your Portfolio Why Pepsi, Time Warner Should Be in Your Portfolio

07/30/15 - 12:25 PM EDT

A drop in commodity prices, a differentiated product line and streamlined operations are helping Pepsi pull even further away from its rival Coke, says Edward Jones strategist Kate Warne.

read more >
Tap Into Pepsi, Time Warner Shares Says Edward Jones Strategist Tap Into Pepsi, Time Warner Shares Says Edward Jones Strategist

07/30/15 - 12:10 PM EDT

A drop in commodity prices, a differentiated product line and streamlined operations are helping Pepsi (PEP) pull even further away from its rival Coke.

read more >
Page 1 of 456
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs